iBio
IBIO
#10436
Rank
NZ$77.26 M
Marketcap
NZ$1.56
Share price
-5.33%
Change (1 day)
9.96%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -NZ$57.42 Million

According to iBio's latest financial reports the company's current earnings are NZ$0.1 Million. In 2025 the company made an earning of -NZ$43.87 Million a decrease over its 2024 earnings that were of -NZ$25.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$57.42 Million30.9%
2025 -NZ$43.87 Million75.34%
2024 -NZ$25.02 Million-32.2%
2023 -NZ$36.9 Million-50.39%
2022 -NZ$74.37 Million122.23%
2021 -NZ$33.47 Million-12.52%
2020 -NZ$38.26 Million45%
2019 -NZ$26.39 Million-3.71%
2018 -NZ$27.4 Million5.52%
2017 -NZ$25.97 Million18.82%
2016 -NZ$21.86 Million60.34%
2015 -NZ$13.63 Million38.31%
2014 -NZ$9.86 Million25.01%
2013 -NZ$7.89 Million
2010 -NZ$21.85 Million360.89%
2009 -NZ$4.75 Million5.77%
2008 -NZ$4.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.79 B-79,539.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-NZ$66.42 Million 12.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 364.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion 188.26%๐Ÿ‡บ๐Ÿ‡ธ USA